TMDX - TransMedics Group, Inc.
About TransMedics Group, Inc. (https://www.transmedics.com)
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Waleed H. Hassanein | Founder, President, Chief Executive Officer & Director | 1968 | $2,191,373 USD |
| Tamer I. Khayal | Senior Vice President of International | 1969 | $1,036,564 USD |
| Gerardo Hernandez | Chief Financial Officer & Treasurer | 1971 | $1,027,912 USD |
| Nicholas Corcoran | Senior Vice President of Supply Chain & Operations | 1982 | $865,837 USD |
| Anil Ranganath | Advisor | 1982 | $634,758 USD |
| Matthew Forsyth | Senior Vice President, General Counsel & Corporate Secretary | – | $594,250 USD |
| Miriam C. Provost | Vice President of Global Regulatory Affairs | 1961 | $535,930 USD |